TAK
Takeda Pharmaceutical·NYSE
--
--(--)
--
--(--)
5.00 / 10
Netural
Technical analysis scores 5.0/10, reflecting a neutral stance. The Marubozu White bullish pattern appears frequently but is counteracted by RSI Overbought signals. Recent data show four instances of Marubozu White and multiple RSI Overbought readings over the last five days, with the latter carrying a bearish bias. Historical win rates (60% for Marubozu White, 47.37% for RSI Overbought) support a neutral trend conclusion, indicating no clear directional momentum.
Analysis Checks(1/2)
RSI Overbought
Score3.17/10
Win Rate47.37%
Hist. Signals19
Avg Return0.40%
Score3.17/10
Win Rate47.37%
Hist. Signals19
Avg Return0.40%
Marubozu White
Score6.83/10
Win Rate60.00%
Hist. Signals40
Avg Return0.65%
Score6.83/10
Win Rate60.00%
Hist. Signals40
Avg Return0.65%
RSI Overbought
Score3.17/10
Win Rate47.37%
Hist. Signals19
Avg Return0.40%
Score3.17/10
Win Rate47.37%
Hist. Signals19
Avg Return0.40%
Marubozu White
Score6.83/10
Win Rate60.00%
Hist. Signals40
Avg Return0.65%
Score6.83/10
Win Rate60.00%
Hist. Signals40
Avg Return0.65%
What is the current technical signals for TAK?
- TAK presents a Netural setup with a Technical Score of 5.00/10. Key technical indicators highlight an RSI of 78.04 and a MACD of 0.17, with the trend anchored by the 50-Day SMA at 15.66. Traders should monitor key support at 17.72 and resistance at 17.91.
